Kong Byung Ho, Park Na-Ri, Shim Jin-Kyoung, Kim Bo-Kyung, Shin Hye-Jin, Lee Ji-Hyun, Huh Yong-Min, Lee Su-Jae, Kim Se-Hoon, Kim Eui-Hyun, Park Eun-Kyung, Chang Jong Hee, Kim Dong-Seok, Kim Sun Ho, Hong Yong-Kil, Kang Seok-Gu, Lang Frederick F
Department of Medical Science, The Catholic University of Korea College of Medicine, Seoul, South Korea.
Childs Nerv Syst. 2013 Feb;29(2):217-29. doi: 10.1007/s00381-012-1964-9. Epub 2012 Nov 10.
The existence of cancer stem cells (CSCs) in glioblastoma has been proposed. However, the unknown knowledge that is yet to be revealed is the presence of glioma CSCs (gCSCs) in correlation to each WHO grades of glioma. We approached this study with a hypothesis that specimens from high-grade gliomas would have higher isolation rate of gCSCs in comparison to those of lower-grade gliomas.
The glioma specimens were obtained from patients and underwent gliomasphere assay. The gliomaspheres were chosen to be analyzed with immunocytochemisty for surface markers. Then the selected gliomaspheres were exposed to neural differentiation conditions. Lastly, we made mouse orthotopic glioma models to examine the capacity of gliomagenesis.
The gliomaspheres were formed in WHO grade IV (13 of 21) and III (two of nine) gliomas. Among them, WHO grade IV (11 of 13) and III (two of two) gliomaspheres showed similar surface markers to gCSCs and were capable of neural differentiation. Lastly, among the chosen cells, 10 of 11 WHO grade IV and two of two WHO grade III gliomaspheres were capable of gliomagenesis. Thus, overall, the rates of existence of gCSCs were more prominent in high-grade gliomas: 47.6% (10 of 21) in WHO grade IV gliomas and 22.2% (two of nine) in WHO grade III gliomas, whereas WHO grade II and I gliomas showed virtually no gCSCs.
This trend of stage-by-stage increase of gCSCs in gliomas showed statistical significance by chi-square test linear-by-linear association. We prove that the rates of existence of gCSCs increase proportionally as the WHO grades of gliomas rise.
有人提出胶质母细胞瘤中存在癌症干细胞(CSCs)。然而,尚未揭示的未知知识是与世界卫生组织(WHO)各胶质瘤分级相关的胶质瘤癌症干细胞(gCSCs)的存在情况。我们带着一个假设开展本研究,即与低级别胶质瘤标本相比,高级别胶质瘤标本中gCSCs的分离率会更高。
从患者获取胶质瘤标本并进行胶质瘤球分析。选择胶质瘤球用免疫细胞化学方法分析表面标志物。然后将选定的胶质瘤球置于神经分化条件下。最后,我们制作小鼠原位胶质瘤模型以检测成瘤能力。
在WHO四级(21例中的13例)和三级(9例中的2例)胶质瘤中形成了胶质瘤球。其中,WHO四级(13例中的11例)和三级(2例中的2例)胶质瘤球显示出与gCSCs相似的表面标志物,并且能够进行神经分化。最后,在选定的细胞中,WHO四级的11例胶质瘤球中有10例以及WHO三级的2例胶质瘤球中有2例具有成瘤能力。因此,总体而言,gCSCs的存在率在高级别胶质瘤中更为显著:WHO四级胶质瘤中为47.6%(21例中的10例),WHO三级胶质瘤中为22.2%(9例中的2例),而WHO二级和一级胶质瘤中几乎没有gCSCs。
通过卡方检验的线性趋势分析,胶质瘤中gCSCs逐阶段增加的这种趋势具有统计学意义。我们证明,随着WHO胶质瘤分级的升高,gCSCs的存在率成比例增加。